Mast cell hyperplasia: Role of cytokines

International Archives of Allergy and Immunology

Volumn 127, Issue 2, 2002, Pages 118-122

  Bischoff, Stephan C ^a   Sellge, Gernot ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Allergy; Inflammatory bowel disease; Interleukin 4; Mast cells; Stem cell factor

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; NERVE GROWTH FACTOR; STEM CELL FACTOR; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL HYPERPLASIA; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHRONIC INFLAMMATION; FIBROSIS; HUMAN; MAST CELL; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; STEM CELL; TUMOR CELL; WOUND HEALING;

CYTOKINES; HUMANS; HYPERPLASIA; INTERLEUKIN-3; INTERLEUKIN-4; MAST CELLS; STEM CELL FACTOR;

EID: 0036207412     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048181     Document Type: Article

References (31)

1. Regulation of human intestinal mast cells
2. Mast cells
3. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells
4. Characterization of mast cell-committed progenitors present in human umbilical cord blood
5. Ultrastructural analysis of maturing human T and TC mast cells in situ
6. Mastocytosis
7. IL-4 enhances proliferation and mediator release in mature human mast cells
8. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes
9. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells
10. Human endothelial cells regulate survival and proliferation of human mast cells
11. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo
12. The potential of human mast cell progenitors to differentiate into mature mast cells remains after prolonged culture with flt3 ligand, interleukin-3 or granulocyte-macrophage colony stimulating factor
13. Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4
14. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI-cell population
15. Failure to detect IL-3-binding sites on human mast cells
16. Phenotypic and functional characterization of mast cells derived from renal tumor tissues
17. Effect of recombinant human IL-4 on tryptase, chymase, and Fcε receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells
18. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation
19. Long-term cultivation of human lung mast cells
20. Human intestinal mast cells are capable of producing different cytokine profiles: Role of IgE receptor cross-linking and IL-4
21. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function
22. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro
23. IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells
24. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors
25. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34+ cord blood cells
26. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, downregulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells
27. Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis
28. Treatment of systemic mastocytosis with interferon-gamma: Failure after appearance of anti-IFN-gamma antibodies
29. Human mast cell migration in response to members of the transforming growth factor-beta family
30. Nerve growth factor prevents apoptosis of cord blood-derived human cultured mast cells synergistically with stem cell factor
31. Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors